Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+121.9%
5Y CAGR+36.9%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+121.9%/yr
vs -2.2%/yr prior
5Y CAGR
+36.9%/yr
Recent acceleration
Acceleration
+124.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $777.78M | +27.8% |
| 2024 | $608.48M | +78.0% |
| 2023 | $341.86M | +380.5% |
| 2022 | $71.14M | -35.3% |
| 2021 | $109.93M | -32.0% |
| 2020 | $161.62M | +94.3% |
| 2019 | $83.18M | +7.0% |
| 2018 | $77.74M | +38.6% |
| 2017 | $56.08M | -16.4% |
| 2016 | $67.06M | - |